Advised on sale of outsourced medical device design, engineering firm

Subscribe to Transaction News

Advised on sale of outsourced medical device design, engineering firm

Subscribe to Transaction News

Stout served as exclusive financial advisor to Rev1 in connection with its sale to Asahi Intecc Co. Rev1 is a cutting-edge outsourced medical device design and engineering firm offering a variety of services, including First of Kind product development, prototype development, design for manufacturing, and product design improvement for next generation devices. The company’s experience spans a wide range of medical device industry sub-segments, including: electroporation; drug/device combination products; structural heart, diagnostic, and interventional catheters; balloons and stent delivery and anchoring systems; neuromodulation; gene therapy delivery; wound closure; and more.

Asahi is a leading global medical device developer, manufacturer and seller of guide wires, guide catheters, and balloon dilatation catheters, which are used in interventional vascular procedures. The company is listed on the first section of the Tokyo Stock Exchange.

View the full news release.